Literature DB >> 31761147

Impact of Lifestyle Modification on Atrial Fibrillation.

Rebecca Wingerter1, Nathaniel Steiger2, Austin Burrows3, N A Mark Estes4.   

Abstract

Atrial Fibrillation (AF) is the most common arrhythmia in adults, and the rapid increase in AF prevalence has been classified by experts as an epidemic. The mechanisms of AF are complex and incompletely understood. While many aspects of management are now based on high quality evidence, other clinical decisions are based on experience and judgment. This article provides an up to date review relating to lifestyle modification and its effect on AF to inform clinical treatment. This comprehensive review used PubMed and Google Scholar to perform keyword searches of articles published between 1998 and the present, with the exception of the 1978 "Holiday Heart" article. Robust data has emerged identifying multiple risk factors for development of AF, including age, sex, hypertension, diabetes mellitus, obesity, alcohol consumption, exercise, and obstructive sleep apnea. Recent evidence indicates that lifestyle modification has a significant role in mitigating the risk and burden of AF. In conclusion, based on the available evidence, an interdisciplinary approach to lifestyle modification will likely reduce risk and/or symptom burden of AF.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31761147     DOI: 10.1016/j.amjcard.2019.10.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Lifestyle modification for the management of atrial fibrillation.

Authors:  Yehia Fanous; Paul Dorian
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

2.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

3.  2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yufeng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Cardiovasc Digit Health J       Date:  2021-01-29

4.  New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.

Authors:  Anders Holt; Gunnar H Gislason; Morten Schou; Bochra Zareini; Tor Biering-Sørensen; Matthew Phelps; Kristian Kragholm; Charlotte Andersson; Emil L Fosbøl; Morten Lock Hansen; Thomas A Gerds; Lars Køber; Christian Torp-Pedersen; Morten Lamberts
Journal:  Eur Heart J       Date:  2020-06-01       Impact factor: 29.983

5. 

Authors:  Yehia Fanous; Paul Dorian
Journal:  CMAJ       Date:  2021-02-01       Impact factor: 8.262

6.  The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis.

Authors:  Sebastian Schnaubelt; Hans Domanovits; Jan Niederdoeckl; Nikola Schuetz; Filippo Cacioppo; Julia Oppenauer; Alexander O Spiel; Anton N Laggner
Journal:  Front Med (Lausanne)       Date:  2020-12-04

7.  Clinical phenotypes of patients with non-valvular atrial fibrillation as defined by a cluster analysis: A report from the J-RHYTHM registry.

Authors:  Eiichi Watanabe; Hiroshi Inoue; Hirotsugu Atarashi; Ken Okumura; Takeshi Yamashita; Eitaro Kodani; Ken Kiyono; Hideki Origasa
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-08

Review 8.  Obstructive Sleep Apnea and Atrial Fibrillation.

Authors:  Amalia Ioanna Moula; Iris Parrini; Cecilia Tetta; Fabiana Lucà; Gianmarco Parise; Carmelo Massimiliano Rao; Emanuela Mauro; Orlando Parise; Francesco Matteucci; Michele Massimo Gulizia; Mark La Meir; Sandro Gelsomino
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

9.  Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p/FOXO3.

Authors:  Jiqiang Hu; Xuan Wang; Xiaoyun Cui; Wu Kuang; Dong Li; Jing Wang
Journal:  Cell Cycle       Date:  2021-06-07       Impact factor: 5.173

10.  Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium.

Authors:  Bente Morseth; Bastiaan Geelhoed; Allan Linneberg; Lars Johansson; Kari Kuulasmaa; Veikko Salomaa; Licia Iacoviello; Simona Costanzo; Stefan Söderberg; Teemu J Niiranen; Julie K K Vishram-Nielsen; Inger Njølstad; Tom Wilsgaard; Ellisiv B Mathiesen; Maja-Lisa Løchen; Tanja Zeller; Stefan Blankenberg; Francisco M Ojeda; Renate B Schnabel
Journal:  Open Heart       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.